Novo Nordisk says Wegovy pill shows comparable weight-loss to injectable version-March 2024-www.financetom.com

Novo Nordisk says Wegovy pill shows comparable weight-loss to injectable version

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novo Nordisk says Wegovy pill shows comparable weight-loss to injectable version

Sep 17, 2025 2:33 PM

Sept 17 (Reuters) - Novo Nordisk's

experimental Wegovy pill showed a 16.6% weight-loss in a

late-stage study, according to data published in The New England

Journal of Medicine on Wednesday, which is comparable to

previous trial results of injectable Wegovy.

(Reporting by Puyaan Singh in Bengaluru; Editing by Shinjini

Ganguli)

Previous page： Metalla Posts Mixed Q1 Report As Moves To Steady the Ship After Nova Royalty Merger Next page： Gates Industrial Starts Secondary Offering of 17.5 Million Shares

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Metalla Posts Mixed Q1 Report As Moves To Steady the Ship After Nova Royalty Merger

May 15, 2024

04:57 PM EDT, 05/15/2024 (MT Newswires) -- Metalla Royalty & Streaming ( MTA ) after trade Wednesday reported results for the first quarter of 2024 that represented something of a steadying of the ship after its recent merger with Nova Royalty. It recognized revenue from royalty and stream interests, including fixed royalty payments, of US$1.3 million, up from nearer US$981,000...

Gates Industrial Starts Secondary Offering of 17.5 Million Shares

May 15, 2024

04:59 PM EDT, 05/15/2024 (MT Newswires) -- Gates Industrial ( GTES ) said Wednesday that affiliates of Blackstone (BX) started a secondary offering of 17.5 million shares of the company. The selling shareholders plan to give underwriters a 30-day option to buy 2.6 million additional shares, according to the company. Gates said it is not selling any shares in the...

Asbury Automotive Says Board Increases Share Buyback Authorization to $400 Million

May 15, 2024

04:57 PM EDT, 05/15/2024 (MT Newswires) -- Asbury Automotive ( ABG ) said late Wednesday its board approved an increase in the share buyback authorization to $400 million. The company repurchased 281,000 shares for $59 million in the year to date. Asbury had $144 million in the existing buyback program and added $246 million to bring the total to $400...

US FDA approves expanded use of Bristol's cancer cell therapy

May 15, 2024

May 15 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved the expanded use of Bristol Myers Squibb's ( BMY ) cancer cell therapy Breyanzi to include the treatment of adults with a type of blood cancer that has returned or has not responded to prior treatments. ...